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0.5%.2 Rate of rupture varied based on size
of aneurysm, location, and gender. In a
more recent case series of relatives of people
who suffered an subarachnoid hemorrhage,
the absolute lifetime risk of subarachnoid
hemorrhage was 4.7% (95% confidence
interval [CI], 3.1–6.3%).2
In a case series of 626 patients having
1 primary relative with ICA, screening
n Evidence summary
In a systematic review of 23 studies involv-
ing 56,304 patients, the prevalence of ICA
varied by the number of family members
affected; 2.3% in general population, 4%
for 1 primary family member affected, and
8% for 2 or more primary family members
affected.1 The annual rate of rupture in a
retrospective study of 1449 patients was
Should people with a first-degree relative
who died from subarachnoid hemorrhage
be screened for aneurysms?
Patients whose family history includes 1 first-
degree relative with subarachnoid hemorrhage
caused by intracranial aneurysm (ICA) need not be
screened for ICAs (strength of recommendation
[SOR]: B, based on a single case series).
Hypertension, hyperlipidemia, ethanol use, and
tobacco use do not increase the risk of ICA for
patients whose primary family member had an ICA
(SOR: B, based on case series). Screening for
intracranial aneurysms is not cost-effective (SOR:
C, mathematical modeling/expert opinion). 
In studies using mathematic modeling, harms
associated with screening (functional impairment,
severe morbidity, or death) would outweigh 
benefits of screening, even for individuals having 
2 or more relatives with ICA (SOR: C). Patients
experience varying levels of psychological distress
when offered screening for ICA (SOR: B).
E V I D E N C E - B A S E D A N S W E R
Although the risk of screening may outweigh the
benefit, it may be worth it for a worried patient
The answer to the question, “Is screening for ICA
appropriate?” depends on who asked it. If you
asked it, prompted by the family history, then the
evidence-based answer may be the most 
appropriate one. However, if the patient poses the
question unsolicited—and is worried sick that they
too will succumb to this abrupt, unpredictable end,
leaving their family behind—then applying the
“common-sense” answer may be most appropri-
ate. The MRI/MRA, in this case, is being used more
to treat the anxiety than to screen for the disease.
Although the risk of screening may outweigh 
the harm from ICA in the general population, 
the benefit may be worth it for the patient who 
is losing sleep and has somatic symptoms as 
a result of the worry.  
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with magnetic resonance imaging (MRI)
and magnetic resonance angiography
(MRA) backup resulted in 0.9 months
increased life expectancy per person
screened, at the cost of 19 years of
decreased function.3 A mathematical
model applied to this study showed that
surgery improved life expectancy by an
average of 2.5 years; a 6-month postoper-
ative functional assessment found func-
tional impairment in 11 of 18 surgical
patients (number needed to harm
[NNH]=1.6). In a separate study using
data from the same population, being a
sibling of an ICA sufferer increased risk of
ICA (relative risk=3.8, though with a wide
95% CI of 1.1–29.3).4 Neither hyperten-
sion nor hypercholesterolemia conferred
increased risk of ICA, and the risk con-
ferred by smoking and use of alcohol was
statistically insignificant.4
In a study of MRA with digital sub-
traction angiography backup, conducted
using theoretical models, screening indi-
viduals having 2 or more first-degree rela-
tives with aneurysm would result in severe
morbidity or death in 26 individuals per
1000 patients screened, vs 15 per 1000
unscreened individuals over a 30-year peri-
od.5 These results were achieved assuming
an ICA prevalence estimate of 9.8%, as
determined from an earlier population
study of individuals with at least 2 first-
degree relatives with ICA. The lower ICA
prevalence rate of 4% for patients with
only 1 primary affected relative would
yield an even more favorable result for not
screening.
A mathematical model for evaluating
cost effectiveness of screening for asympto-
matic intracranial aneurysms in the gener-
al population determined there is a quality-
adjusted life-year reduction for presumed
ICA prevalence rates as high as 10%, given
an annual rate of rupture of 0.05%.6 The
average cost was $1121 for those who
underwent screening vs $147 for those
who did not. The presumed variables of
prevalence, annual rates of ICA rupture,
and surgical mortality and morbidity
greatly influenced cost-effectiveness.
Screening could be reasonable in popula-
tions with higher rupture rates, and if sur-
gical morbidity and mortality decline.  
Recently, the psychosocial aspects of
screening for ICA have been studied. In 
1 case series of 105 patients, 35 screen-pos-
itive patients scored lower for quality of life
than 70 screen-negative patients. However,
only 3 patients regretted participating in
screening.7 An observational study of 980
first-degree relatives of patients with sub-
arachnoid hemorrhage determined that
offering screening for ICA did not provoke
anxiety or depression.8 Providing thorough
counseling before screening can help to
alleviate the patient’s anxiety.
Recommendations from others
In 2000, the Stroke Council of the
American Heart Association concluded
that screening is not efficacious in popula-
tions having a single first-degree relative
with aneurismal subarachnoid hemor-
rhage or intracranial aneurysm.9
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